Trump ENDS Biden’s Fetal Tissue Madness

Person holding a sign that reads FEDERAL FUNDS in front of an American flag

President Trump’s administration has delivered a resounding victory for pro-life values by permanently ending all NIH funding for research using tissue from aborted babies, rejecting the ethical nightmare funded under Biden.

Story Highlights

NIH bans all federal funding for research using fetal tissue from elective abortions, affecting 77 projects and $53 million in FY2024 spending.
This harsher policy expands Trump’s 2019 restrictions, now covering both internal NIH work and all external grants nationwide.
Tissue from miscarriages and stillbirths remains allowed, prioritizing ethical alternatives like organoids and tissue chips.
Pro-life groups celebrate taxpayer dollars no longer supporting abortion industry profits, fulfilling promises to conservative families.
Scientific elite warn of delays, but administration insists cutting-edge tech advances real progress without moral compromise.

Trump Administration Delivers Comprehensive Ban

NIH Director Jay Bhattacharya announced on January 22, 2026, that federal funds will no longer support research involving human fetal tissue from elective abortions. This policy prohibits such research across all NIH intramural programs, grants, cooperative agreements, contracts, and other awards. The decision redirects resources from 77 projects funded in Fiscal Year 2024, which received $53 million. Existing grants can be rebudgeted for ethical alternatives, ensuring continuity without ethical violations. This move fulfills President Trump’s commitment to protect unborn life and taxpayer integrity.

Reversing Biden’s Reckless Reversal

Biden’s April 2021 policy scrapped Trump’s original June 2019 restrictions, resuming internal NIH fetal tissue research and dismantling the ethics review board. That board had rejected 13 of 14 external grant applications in August 2020, prioritizing moral standards over profit-driven science. Funding peaked at $115 million in 2018 but declined to $53 million by 2024 amid growing opposition. The new ban is broader, eliminating all such research rather than just internal work, decisively ending Biden-era overreach that forced conservatives to fund abortion-linked experiments.

Ethical Science Through Superior Alternatives

NIH justifies the ban by citing advances in organoids, tissue chips, computational biology, and other platforms that deliver robust results without ethical concerns. These technologies ensure taxpayer-funded research remains scientifically rigorous and morally sound. Exemptions persist for tissue from miscarriages and stillbirths under strict documentation rules. White Coat Waste helped identify 17 projects for termination in September 2025, accelerating the shift. This prioritizes innovation that aligns with family values and limited government waste.

Pro-life advocates hail the policy as a win against using aborted fetal tissue, long criticized as complicit in the abortion industry. Robert F. Kennedy Jr., overseeing HHS, supports advancing ethical priorities. The ban redirects funds amid Congress’s planned $415 million NIH budget boost, investing in American ingenuity over controversial practices.

Scientific Pushback Meets Conservative Resolve

The International Society for Stem Cell Research claims fetal tissue is the “gold standard” for studying diseases like cancer, HIV, and neurological disorders, warning of therapeutic delays. Tyler Lamb argued it slows innovation for patients. Yet NIH emphasizes alternatives are often superior, countering claims of irreplaceable loss. Historical use dates to the 1930s, but modern tools now dominate, protecting conservative principles of life from conception while fostering true scientific progress.

This policy strengthens U.S. leadership in ethical biomedical research, shielding families from government complicity in elective abortions. Conservatives frustrated by past woke science agendas now see real change under Trump, restoring trust in federal spending.